Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
128,581
-
Share change
-
+128,581
-
Total reported value
-
$143,186
-
Price per share
-
$1.11
-
Number of holders
-
7
-
Value change
-
+$143,186
-
Number of buys
-
7
Institutional Holders of Estrella Immunopharma, Inc. - COM (ESLA) as of Q4 2023
As of 31 Dec 2023,
Estrella Immunopharma, Inc. - COM (ESLA) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
128,581 shares.
The largest 7 holders included
GEODE CAPITAL MANAGEMENT, LLC, ATW SPAC MANAGEMENT LLC, Hunting Hill Global Capital, LLC, Maso Capital Partners Ltd, Tower Research Capital LLC (TRC), UBS Group AG, and WELLS FARGO & COMPANY/MN.
This page lists
7
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.